A donor’s drug profile is one reason for deferral, if there are safety concerns for either donor or recipient.
Historically, cardiac fibrosis has not been a focus for treatment; however, it is now believed that therapy could reduce the progression of heart failure and other cardiovascular diseases.
Adverse effects, primarily cardiovascular in nature, are of concern because of their severe and possibly chronic nature.
Digoxin, a cardiac glycoside, has inotropic effects in addition to effects on cardiac output.
The pathophysiology is not fully understood, rendering pharmacologic treatment difficult.
No true antidote for these agents has been developed, so patients requiring rapid reversal must be appropriately monitored and managed.
Testing for the inflammatory marker CRP may improve risk stratification, especially in intermediate-risk patients.
Endometriosis is a chronic, recurrent disease caused by the extrauterine presence of endometrial tissues.
Up to 40% of patients undergoing chemotherapy with multiple agents experience nerve damage.
Mental health disorders are frequently seen in patients with Parkinson’s disease, possibly as a result of the complex imbalance of neurotransmitters in both disease states.
Cannabis, the substance more commonly known as marijuana, has gained interest in recent years for its potential use as an antiepileptic agent.
Despite the benefits of consistent CPAP therapy, adherence remains a challenge.
Gastroparesis is a syndrome of delayed gastric emptying caused by factors other than mechanical obstructions in the stomach.
The 2014 outbreak in West Africa is the largest epidemic to date. Preventive strategies and supportive therapy are the only options, since no vaccine or effective antiviral treatment is yet available.
Pharmacists can oversee postprocedural treatment administered to prevent atrioesophageal fistula, a serious complication.
Liver cirrhosis is the end result of several mechanisms of liver inflammation caused by chronic liver disease, genetic disease, or autoimmune inflammation.
Recent studies have shown that drug absorption may be impaired in CD patients who require oral medications for comorbid conditions.
The most important risk factor for acquiring this virulent infection is antibiotic administration.
Patients with diabetes often experience foot complications, such as ulcers, infections, and even amputations.1
Adverse drug events are an important factor influencing health outcomes of individuals treated with psychotropic medications.
For more articles, please check our archives.